140
Views
9
CrossRef citations to date
0
Altmetric
Articles

An oncogenic activity of PDGF-C and its splice variant in human breast cancer

, , , , , , , , , & show all
Pages 131-145 | Received 17 Mar 2019, Accepted 26 Aug 2019, Published online: 23 Sep 2019

References

  • Anderberg, C., H. Li, L. Fredriksson, J. Andrae, C. Betsholtz, X. Li, U. Eriksson, and K. Pietras. 2009. “Paracrine Signaling by Platelet-Derived Growth factor-CC Promotes Tumor Growth by Recruitment of Cancer-Associated Fibroblasts.” Cancer Research 69 (1): 369–378.
  • Andrae, J., C. Molander, A. Smits, K. Funa, and M. Nister. 2002. “Platelet-Derived Growth factor-B and -C and Active Alpha-Receptors in Medulloblastoma Cells.” Biochemical and Biophysical Research Communications 296 (3): 604–611.
  • Bronzert, D. A., P. Pantazis, H. N. Antoniades, A. Kasid, N. Davidson, R. B. Dickson, and M. E. Lippman. 1987. “Synthesis and Secretion of Platelet-Derived Growth Factor by Human Breast Cancer Cell Lines.” Proceedings of the National Academy of Sciences of Sciences 84 (16): 5763–5767.
  • Carvalho, I., F. Milanezi, A. Martins, R. M. Reis, and F. Schmitt. 2005. “Overexpression of Platelet-Derived Growth Factor Receptor Alpha in Breast Cancer is Associated with Tumour Progression.” Breast Cancer Research 7 (5): R788–795.
  • Coltrera, M. D., J. Wang, P. L. Porter, and A. M. Gown. 1995. “Expression of Platelet-Derived Growth Factor B-Chain and the Platelet-Derived Growth Factor Receptor Beta Subunit in Human Breast Tissue and Breast Carcinoma.” Cancer Research 55 (12): 2703–2708.
  • Crawford, Y., I. Kasman, L. Yu, C. Zhong, X. Wu, Z. Modrusan, J. Kaminker, and N. Ferrara. 2009. “PDGF-C Mediates the Angiogenic and Tumorigenic Properties of Fibroblasts Associated with Tumors Refractory to anti-VEGF Treatment.” Cancer Cell 15 (1): 21–34.
  • di Tomaso, E., N. London, D. Fuja, J. Logie, J. A. Tyrrell, W. Kamoun, L. L. Munn, and R. K. Jain. 2009. “PDGF-C Induces Maturation of Blood Vessels in a Model of Glioblastoma and Attenuates the Response to anti-VEGF Treatment.” PLoS One 4 (4): e5123.
  • Dickson, R. B., S. E. Bates, M. E. McManaway, and M. E. Lippman. 1986. “Characterization of Estrogen Responsive Transforming Activity in Human Breast Cancer Cell Lines.” Cancer Research 46 (4 Pt 1): 1707–1713.
  • Doolittle, R. F., M. W. Hunkapiller, L. E. Hood, S. G. Devare, K. C. Robbins, S. A. Aaronson, and H. N. Antoniades. 1983. “Simian Sarcoma Virus Onc Gene, v-Sis, Is Derived from the Gene (or Genes) Encoding a Platelet-Derived Growth Factor.” Science 221 (4607): 275–277.
  • Fredriksson, L., H. Li, C. Fieber, X. Li, and U. Eriksson. 2004. “Tissue Plasminogen Activator is a Potent Activator of PDGF-CC.” The EMBO Journal 23 (19): 3793–3802.
  • Gilbertson, D. G., M. E. Duff, J. W. West, J. D. Kelly, P. O. Sheppard, P. D. Hofstrand, Z. Gao, K. Shoemaker, T. R. Bukowski, M. Moore., et al. 2001. “Platelet-Derived Growth Factor C (PDGF-C), a Novel Growth Factor That Binds to PDGF Alpha and Beta Receptor.” Journal of Biological Chemistry 276 (29): 27406–27414.
  • Hurst, N. J., A. J. Najy, C. V. Ustach, L. Movilla, and H. R. Kim. 2012. “Platelet-Derived Growth factor-C (PDGF-C) Activation by Serine Proteases: Implications for Breast Cancer Progression.” Biochemical Journal 441 (3): 909–918.
  • Huseby, R. A., T. M. Maloney, and C. M. McGrath. 1984. “Evidence for a Direct Growth-Stimulating Effect of Estradiol on Human MCF-7 Cells in Vivo.” Cancer Research 44 (6): 2654–2659.
  • Imamura, T., K. Engleka, X. Zhan, Y. Tokita, R. Forough, D. Roeder, A. Jackson, J. A. Maier, T. Hla, and T. Maciag. 1990. “Recovery of Mitogenic Activity of a Growth Factor Mutant with a Nuclear Translocation Sequence.” Science 249 (4976): 1567–1570.
  • Jechlinger, M., A. Sommer, R. Moriggl, P. Seither, N. Kraut, P. Capodiecci, M. Donovan, C. Cordon-Cardo, H. Beug, and S. Grunert. 2006. “Autocrine PDGFR Signaling Promotes Mammary Cancer Metastasis.” Journal of Clinical Investigation 116 (6): 1561–1570.
  • Kelly, K.,. B. H. Cochran, C. D. Stiles, and P. Leder. 1983. “Cell-Specific Regulation of the c-Myc Gene by Lymphocyte Mitogens and Platelet-Derived Growth Factor.” Cell 35 (3): 603–610.
  • Kimura, H. 1993. “Schwannoma-derived growth factor must be transported into the nucleus to exert its mitogenic activity.” Proceedings of the National Academy of Sciences of the United States of America 90 (6): 2165–2169.
  • LaRochelle, W. J., M. Jeffers, W. F. McDonald, R. A. Chillakuru, N. A. Giese, N. A. Lokker, C. Sullivan, F. L. Boldog, M. Yang, C. Vernet., et al. 2001. “PDGF-D, a New Protease-Activated Growth Factor.” Nature Cell Biology 3 (5): 517–521.
  • Lev, D. C., S. J. Kim, A. Onn, V. Stone, D. H. Nam, S. Yazici, I. J. Fidler, and J. E. Price. 2005. “Inhibition of Platelet-Derived Growth Factor Receptor Signaling Restricts the Growth of Human Breast Cancer in the Bone of Nude Mice.” Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 11: 306–314.
  • Li, G., R. Fridman, and H. R. Kim. 1999. “Tissue Inhibitor of Metalloproteinase-1 Inhibits Apoptosis of Human Breast Epithelial Cells.” Cancer Research 59 (24): 6267–6275.
  • Li, X., A. Ponten, K. Aase, L. Karlsson, A. Abramsson, M. Uutela, G. Backstrom, M. Hellstrom, H. Bostrom, H. Li., et al. 2000. “PDGF-C is a New Protease-Activated Ligand for the PDGF Alpha-Receptor.” Nature Cell Biology 2 (5): 302–309.
  • Lokker, N. A., C. M. Sullivan, S. J. Hollenbach, M. A. Israel, and N. A. Giese. 2002. “Platelet-Derived Growth Factor (PDGF) Autocrine Signaling Regulates Survival and Mitogenic Pathways in Glioblastoma Cells: Evidence That the Novel PDGF-C and PDGF-D Ligands May Play a Role in the Development of Brain Tumors.” Cancer Research 62 (13): 3729–3735.
  • Moll, R., W. W. Franke, D. L. Schiller, B. Geiger, and R. Krepler. 1982. “The Catalog of Human Cytokeratins: Patterns of Expression in Normal Epithelia, Tumors and Cultured Cells.” Cell 31 (1): 11–24.
  • Neve, R. M., K. Chin, J. Fridlyand, J. Yeh, F. L. Baehner, T. Fevr, L. Clark, N. Bayani, J. P. Coppe, F. Tong., et al. 2006. “A Collection of Breast Cancer Cell Lines for the Study of Functionally Distinct Cancer Subtypes.” Cancer Cell 10 (6): 515–527.
  • Ostman, A., J. Thyberg, B. Westermark, and C. H. Heldin. 1992. “PDGF-AA and PDGF-BB Biosynthesis: Proprotein Processing in the Golgi Complex and Lysosomal Degradation of PDGF-BB Retained Intracellularly.” The Journal of Cell Biology 118 (3): 509–519.
  • Palman, C., D. F. Bowen-Pope, and J. J. Brooks. 1992. “Platelet-Derived Growth Factor Receptor (Beta-Subunit) Immunoreactivity in Soft Tissue Tumors.” Laboratory Investigation; a Journal of Technical Methods and Pathology 66 (1): 108–115.
  • Park, S. Y., H. E. Lee, H. Li, M. Shipitsin, R. Gelman, and K. Polyak. 2010. “Heterogeneity for Stem Cell-Related Markers according to Tumor Subtype and Histologic Stage in Breast Cancer.” Clinical Cancer Research 16 (3): 876–887.
  • Paulsson, J., T. Sjoblom, P. Micke, F. Ponten, G. Landberg, C. H. Heldin, J. Bergh, D. J. Brennan, K. Jirstrom, and A. Ostman. 2009. “Prognostic Significance of Stromal Platelet-Derived Growth Factor Beta-Receptor Expression in Human Breast Cancer.” The American Journal of Pathology 175 (1): 334–341.
  • Reigstad, L. J., A. Martinez, J. E. Varhaug, and J. R. Lillehaug. 2006. “Nuclear Localisation of Endogenous SUMO-1-Modified PDGF-C in Human Thyroid Tissue and Cell Lines.” Experimental Cell Research 312 (6): 782–795.
  • Ringner, M., E. Fredlund, J. Hakkinen, A. Borg, and J. Staaf. 2011. “GOBO: Gene Expression-Based Outcome for Breast Cancer Online.” PLoS One 6 (3): E 17911.
  • Rosenkranz, S., and A. Kazlauskas. 1999. “Evidence for Distinct Signaling Properties and Biological Responses Induced by the PDGF Receptor Alpha and Beta Subtypes.” Growth Factors (Chur, Switzerland) 16 (3): 201–216.
  • Sartor, C. I., M. L. Dziubinski, C. L. Yu, R. Jove, and S. P. Ethier. 1997. “Role of Epidermal Growth Factor Receptor and STAT-3 Activation in Autonomous Proliferation of SUM-102PT Human Breast Cancer Cells.” Cancer Research 57 (5): 978–987.
  • Schafer, J. M., E. S. Lee, R. M. O'Regan, K. Yao, and V. C. Jordan. 2000. “Rapid Development of Tamoxifen-Stimulated Mutant p53 Breast Tumors (T47D) in Athymic Mice.” Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 6: 4373–4380.
  • Seymour, L., and W. R. Bezwoda. 1994. “Positive Immunostaining for Platelet Derived Growth Factor (PDGF) Is an Adverse Prognostic Factor in Patients with Advanced Breast Cancer.” Breast Cancer Research and Treatment 32 (2): 229–233.
  • Singh, D. P., N. Fatma, A. Kimura, L. T. Chylack, Jr., and T. Shinohara. 2001. “LEDGF Binds to Heat Shock and Stress-Related Element to Activate the Expression of Stress-Related Genes.” Biochemical and Biophysical Research Communications 283 (4): 943–955.
  • Sommers, C. L., E. P. Gelmann, R. Kemler, P. Cowin, and S. W. Byers. 1994. “Alterations in Beta-Catenin Phosphorylation and Plakoglobin Expression in Human Breast Cancer Cells.” Cancer Research 54 (13): 3544–3552.
  • Soule, H. D., T. M. Maloney, S. R. Wolman, W. D. Peterson, Jr., R. Brenz, C. M. McGrath, J. Russo, R. J. Pauley, R. F. Jones, and S. C. Brooks. 1990. “Isolation and Characterization of a Spontaneously Immortalized Human Breast Epithelial Cell Line, MCF-10.” Cancer Research 50 (18): 6075–6086.
  • Ustach, C. V., and H. R. Kim. 2005. “Platelet-Derived Growth Factor D is Activated by Urokinase Plasminogen Activator in Prostate Carcinoma Cells.” Molecular and Cellular Biology 25 (14): 6279–6288.
  • Ustach, C. V., M. E. Taube, N. J. Hurst, Jr., S. Bhagat, R. D. Bonfil, M. L. Cher, L. Schuger, and H. R. Kim. 2004. “A Potential Oncogenic Activity of Platelet-Derived Growth Factor d in Prostate Cancer Progression.” Cancer Research 64 (5): 1722–1729.
  • Van den Eynden, G. G., S. J. Van Laere, I. Van der Auwera, S. D. Merajver, E. A. Van Marck, P. van Dam, P. B. Vermeulen, L. Y. Dirix, and K. L. van Golen. 2006. “Overexpression of Caveolin-1 and -2 in Cell Lines and in Human Samples of Inflammatory Breast Cancer.” Breast Cancer Research and Treatment 95 (3): 219–228.
  • Waterfield, M. D., G. T. Scrace, N. Whittle, P. Stroobant, A. Johnsson, A. Wasteson, B. Westermark, C. H. Heldin, J. S. Huang, and T. F. Deuel. 1983. “Platelet-Derived Growth Factor Is Structurally Related to the Putative Transforming Protein p28sis of Simian Sarcoma Virus.” Nature 304 (5921): 35–39.
  • Wesche, Jørgen, Jȩdrzej Małecki, Antoni WiȩDłocha, Maryam Ehsani, Ewa Marcinkowska, Trine Nilsen, and, and Sjur Olsnes, 2005. “Two Nuclear Localization Signals Required for Transport from the Cytosol to the Nucleus of Externally Added FGF-1 Translocated into Cells.” Biochemistry 44 (16): 6071–6080.
  • Willmarth, N. E., and S. P. Ethier. 2006. “Autocrine and Juxtacrine Effects of Amphiregulin on the Proliferative, Invasive, and Migratory Properties of Normal and Neoplastic Human Mammary Epithelial Cells.” Journal of Biological Chemistry 281 (49): 37728–37737.
  • Yamano, Y.,. K. Uzawa, K. Saito, D. Nakashima, A. Kasamatsu, H. Koike, Y. Kouzu, K. Shinozuka, K. Nakatani, K. Negoro., et al. 2010. “Identification of Cisplatin-Resistance Related Genes in Head and Neck Squamous Cell Carcinoma.” International Journal of Cancer 126 (2): 437–449.
  • Yu, J., C. Ustach, and H. R. Kim. 2003. “Platelet-Derived Growth Factor Signaling and Human Cancer.” Bmb Reports 36 (1): 49–59.
  • Zhao, J., Z. Liu, T. Liu, S. Nilsson, and M. Nister. 2008. “Identification and Expression Analysis of an N-Terminally Truncated Isoform of Human PDGF-C.” Experimental Cell Research 314 (14): 2529–2543.
  • Zwerner, J. P., and W. A. May. 2001. “PDGF-C is an EWS/FLI Induced Transforming Growth Factor in Ewing Family Tumors.” Oncogene 20 (5): 626–633.
  • Zwerner, J. P., and W. A. May. 2002. “Dominant Negative PDGF-C Inhibits Growth of Ewing Family Tumor Cell Lines.” Oncogene 21 (24): 3847–3854.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.